In recent years, a revolutionary class of medications known as GLP-1 receptor agonists has transformed the landscape of medical weight management
Independent pharmacokinetic comparison studies are limited
AOD aids in fat loss and muscle health, while BPC-157 promotes tissue repair and reduces inflammation
Hydration Reduced appetite, vomiting or diarrhoea while using Mounjaro can increase the risk of dehydration
Initially developed for managing type 2 diabetes, theyve also been shown to lead to significant weight loss, which has led to their off-label and approved use in people without diabetes
Our weight loss doctors near you will help choose the best option based on your health profile, preferences, and whether it is a weight loss medication covered by insurance